Primary cutaneous apocrine carcinoma versus metastasis, a plea to the dermatopathology community

American Journal of Dermatopathology

Volumn 32, Issue 8, 2010, Pages 853-854

  Fernandez Flores, Angel ^a  

^a Service of Cellular Pathology   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CYTOKERATIN 5; CYTOKERATIN 6; CYTOKERATIN 7; EPIDERMAL GROWTH FACTOR RECEPTOR; ESTROGEN RECEPTOR; GROSS CYSTIC DISEASE FLUID PROTEIN 15; MAMMAGLOBIN; PROGESTERONE RECEPTOR; PROTEIN P63; UNCLASSIFIED DRUG;

APOCRINE CARCINOMA; BREAST CARCINOMA; CUTANEOUS APOCRINE CARCINOMA; DIFFERENTIAL DIAGNOSIS; HUMAN; IMMUNOHISTOCHEMISTRY; INTRADUCTAL CARCINOMA; LETTER; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

APOCRINE GLANDS; BREAST NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; NEOPLASMS, ADNEXAL AND SKIN APPENDAGE; NEOPLASMS, SECOND PRIMARY; PREDICTIVE VALUE OF TESTS; TUMOR MARKERS, BIOLOGICAL;

EID: 78650416597     PISSN: 01931091     EISSN: None     Source Type: Journal    
DOI: 10.1097/DAD.0b013e3181bbc473     Document Type: Letter

References (34)

1. Cangelosi JJ, Nash JW, Prieto VG, et al. Cutaneous adnexal tumor with an unusual presentationddiscussion of a potential diagnostic pitfall. Am J Dermatopathol. 2009;31: 278-281.
2. Kazakov DV, Kutzner H, Spagnolo DV, et al. Sebaceous differentiation in poroid neoplasms: report of 11 cases, including a case of meta-plastic carcinoma associated with apocrine poroma (sarcomatoid apocrine porocarcinoma). Am J Dermatopathol. 2008;30:21-26.
3. Plumb SJ, Argenyi ZB, Stone MS, et al. Cytokeratin 5/6 immunostaining in cutaneous adnexal neoplasms and metastatic adenocarci-noma. Am J Dermatopathol. 2004;26:447-451.
4. Ivan D, Diwan AH, Prieto VG. Expression of p63 in primary cutaneous adnexal neoplasms and adenocarcinoma metastatic to the skin. Mod Pathol. 2005;18:137-142.
5. Ivan D, Nash JW, Prieto VG, et al. Use of p63 expression in distinguishing primary and metastatic cutaneous adnexal neoplasms from metastatic adenocarcinoma to the skin. J Cutan Pathol. 2007;34: 474-480.
6. Robson A, Lazar AJ, Ben Nagi J, et al. Primary cutaneous apocrine carcinoma: a clinico-patho-logic analysis of 24 cases. Am J Surg Pathol. 2008;32:682-690.
7. Watson MA, Dintzis S, Darrow CM, et al. Mammaglobin expression in primary, meta-static, and occult breast cancer. Cancer Res. 1999;59:3028-3031.
8. Katagiri Y, Ansai S. Two cases of cutaneous apocrine ductal carcinoma of the axilla. Dermatology. 1999;199:332-337.
9. Ohnishi T, Watanabe S. The use of cytokeratins 7 and 20 in the diagnosis of primary and secondary extramammary Paget's disease. Br J Dermatol. 2000;142:243-247.
10. Cameseille-Teijeiro J, Cameseille-Teijeiro JF. Homologous carcinomas of the breast and skin. Am J Clin Pathol. 1999;111:709-712.
11. Miyamoto T, Hagari Y, Inoue S, et al. Axillary apocrine carcinoma with benign apocrine tumours: a case report involving a pathological and immunohistochemical study and review of the literature. J Clin Pathol. 2005;58:757-761.
12. Nishikawa Y, Tokushashi Y, Saito Y, et al. A case of apocrine adenocarcinoma associated with hamartomatous apocrine gland hyperpla-sia of both axillae. Am J Surg Pathol. 1994;18: 832-836.
13. Wick MR, Ockner DM, Mills SE, et al. Homologous carcinomas of the breast, skin, and salivary glands. A histologic and immu-nohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol. 1998;109:75-84.
14. Ansai S, Koseki S, Hozumi Y, et al. An immu-nohistochemical study of lysozyme, CD-15 (Leu M1), and gross cystic disease fluid protein-15 in various skin tumors. Assessment of the specificity and sensitivity of markers of apocrine differentiation. Am J Dermatopathol. 1995;17: 249-255.
15. Qureshi HS, Ormsby AH, Lee MW, et al. The diagnostic utility of p63, CK5/6, CK7, and CK20 in distinguishing primary cutaneous adnexal neoplasms from metastatic carcinomas. J Cutan Pathol. 2004;31:145-152.
16. Shin BK, Lee Y, Lee JB, et al. Breast carcinomas expressing basal markers have poor clinical outcome regardless of estrogen receptor status. Oncol Rep. 2008;19:617-625.
17. Fernandez-Flores A, Pol A, Juanes F, et al. Immunohistochemical phenotype of cutaneous cribriform carcinoma with a panel of 15 antibodies. Med Mol Morphol. 2007;40:212-217.
18. Busam KJ, Tan LK, Granter SR, et al. Epidermal growth factor, estrogen, and progesterone receptor expression in primary sweat gland carcinomas and primary and metastatic mammary carcinomas. Mod Pathol. 1999;12: 786-793.
19. Brandt SM, Swistel AJ, Rosen PP. Secretory carcinoma in the axilla: probable origin from axillary skin appendage glands in a young girl. Am J Surg Pathol. 2009;33:950-953.
20. Ackerman AB, Kessler G, Gyorfi T, et al. Contrary view: the breast is not an organ per se, but a distinctive region of skin and subcutaneous tissue. Am J Dermatopathol. 2007;29:211-218.
21. Ackerman AB. The breast is not an organ. Am J Dermatopathol. 2008;30:304.
22. Fernandez-Flores A. Mammaglobin immunos-taining in the differential diagnosis between cutaneous apocrine carcinoma and cutaneous metastasis from breast carcinoma. Cesk Patol. In press.
23. Fanger GR, Houghton RL, Retter MW, et al. Detection of mammaglobin in the sera of patients with breast cancer. Tumour Biol. 2000; 23:212-221.
24. Colpitts TL, Billing-Medel P, Friedman P, et al. Mammaglobin is found in breast tissue as a complex with BU101. Biochemistry. 2001; 40:11048-11059.
25. Bhargava R, Beriwal S, Dabbs DJ. Mamma-globin vs GCDFP-15: an immunohistologic validation survey for sensitivity and specificity. Am J Clin Pathol. 2007;127:103-113.
26. Sasaki E, Tsunoda N, Hatanaka Y, et al. Breast-specific expression of MGB1/mamma-globin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancers. Mod Pathol. 2007;20:208-214.
27. Sjödin A, Guo D, Hofer P-A, et al. Mamma-globin in normal human sweat glands and human sweat gland tumors. J Invest Dermatol. 2003;121:428-429.
28. Maiorana A, Nigrisoli E, Papotti M. Immuno-histochemical markers of sweat gland tumors. J Cutan Pathol. 1986;13:187-196.
29. Penneys NS, Kaiser M. Cylindroma expresses immunohistochemical markers linking it to eccrine coil. J Cutan Pathol. 1993;20:40-43.
30. Reynes M, Puissant A, Delanoe J, et al. Ultrastructural study of cylindroma (Poncet-Spiegler tumor). J Cutan Pathol. 1976;3: 95-101.
31. Kwittken J. The hyaline eccrinoma. Mt Sinai J Med. 1981;48:426-430.
32. Cotton DW, Braye SG. Dermal cylindromas originate from the eccrine sweat gland. Br J Dermatol. 1984;111:53-61.
33. Hashimoto K, Lever WF. Histogenesis of skin appendage tumors. Arch Dermatol. 1969;100: 356-369.
34. Tsambaos D, Greither A, Orfanos CE. Multiple malignant Spiegler tumors with brachydactyly and racket-nails. Light and electron microscopic study. J Cutan Pathol. 1979;6:31-41.